Introduction The aim of this study is to analyze all metastatic (M) categories of the current
tumor, node, and metastasis (TNM) classification of lung cancer with the objective of …

Abstract Introduction/Background An individual patient data metaanalysis was performed to
determine clinical outcomes, and to propose a risk stratification system, related to the …

Clinical reports of limited and treatable cancer metastases, a disease state that exists in a
transitional zone between localized and widespread systemic disease, were noted on …

Simple Summary The management strategy for the treatment of non-small-cell lung cancer
(NSCLC) has been transformed by our improved understanding of the cancer biology and …

Importance Intracranial metastatic disease (IMD) is a severe complication of cancer with
profound prognostic implications. Patients with IMD in the setting of limited or stable …

Objectives Metastatic non-small cell lung carcinoma (NSCLC) generally carries a poor
prognosis, and systemic therapy is the mainstay of treatment. However, extended survival …

Lung cancer remains the leading cause of cancer-related mortality worldwide. To formulate
effective treatment strategies and optimize patient outcomes, accurate staging is essential …

Introduction Multiple nodules in the lung are being diagnosed with an increasing frequency
thanks to high-quality computed tomography imaging. In patients with lung cancer, this …

Introduction In most patients with NSCLC, the disease is diagnosed in an advanced stage,
the prognosis is poor, and survival is typically measured in months. Standard therapeutic …

Brain metastases are a common occurrence in both non-small cell and small cell lung
cancer with the potential to affect quality of life and prognosis. Due to concerns about the …